Showing results (231-240 of 263) with videos related to
Sort By:
Pageof 27
Thoracic Cancer|July 13, 2021
Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysisShinnosuke Takemoto, Kazumasa Akagi, Sawana Ono, et al.Thoracic Cancer|February 19, 2021
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case reportHirokazu Taniguchi, Shinnosuke Takemoto, Mutsumi Ozasa, et al.British Journal of Haematology|May 11, 2012
De novo childhood myelodysplastic/myeloproliferative disease with unique molecular characteristicsOlfat Ismael, Akira Shimada, Asahito Hama, et al.Lung Cancer (Amsterdam, Netherlands)|May 18, 2019
Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)Minoru Fukuda, Takeshi Kitazaki, Daiki Ogawara, et al.Nature Medicine|October 7, 2008
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisRenate Kain, Markus Exner, Ricarda Brandes, et al.Glycoconjugate Journal|December 18, 2008
The N-glycolyl form of mouse sialyl Lewis X is recognized by selectins but not by HECA-452 and FH6 antibodies that were raised against human cellsJunya Mitoma, Tatsuo Miyazaki, Mark Sutton-Smith, et al.Thoracic Cancer|December 19, 2019
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM studyShinnosuke Takemoto, Minoru Fukuda, Hiroyuki Yamaguchi, et al.Plos One|August 17, 2013
Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migrationYousef M J Al-Saraireh, Mark Sutherland, Bradley R Springett, et al.Journal of Thoracic Disease|October 29, 2025
A phase II clinical trial on the efficacy and safety of carboplatin plus nab-paclitaxel in chemotherapy-naive advanced or recurrent thymic epithelial tumors: protocol of Nab-TETFumiko Hayashi, Midori Matsuo, Shinnosuke Takemoto, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2019
Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti-Programmed Cell Death-1 Therapy in NSCLCYoshihiro Ohue, Koji Kurose, Takahiro Karasaki, et al.Pageof 27